表紙
市場調査レポート

欧州主要5カ国の遺伝子検査市場の将来展望

EU5 Genetic Testing Market Outlook to 2021

発行 GlobalData 商品コード 348472
出版日 ページ情報 英文 147 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.71円で換算しております。
Back to Top
欧州主要5カ国の遺伝子検査市場の将来展望 EU5 Genetic Testing Market Outlook to 2021
出版日: 2015年10月05日 ページ情報: 英文 147 Pages
概要

当レポートでは、欧州の主要5か国における遺伝子検査 (後天性遺伝子・染色体異変、先天性遺伝子・染色体異変など) の市場について分析し、地域全体の市場規模の動向見通し (金額ベース、過去・今後8年間分) や、各国レベルでの詳細動向、主要企業・流通チャネルの市場シェア、主要企業のプロファイル、最新の市場動静(資本取引など)などについて調査・考察しております。

第1章 目次

第2章 イントロダクション

  • 当レポートの概要
  • 遺伝子検査市場の内訳
  • 分析対象市場の定義

第3章 欧州主要5カ国の遺伝子検査市場

  • 市場収益額:総額 (通算15年間分)
  • 市場収益額:カテゴリー別の内訳 (通算15年間分)
  • 市場収益額の実績値:金額ベース (過去8年間分)
  • 市場収益額の予測値:金額ベース (今後8年間分)
  • 市場収益額シェア:企業別

第4章 フランスの遺伝子検査市場

  • 市場収益額の実績値:金額ベース (過去8年間分)
  • 市場収益額の予測値:金額ベース (今後8年間分)
  • 市場収益額シェア:流通チャネル別
  • 市場収益額シェア:企業別

第5章 ドイツの遺伝子検査市場

第6章 イタリアの遺伝子検査市場

第7章 スペインの遺伝子検査市場

第8章 英国の遺伝子検査市場

第9章 欧州の遺伝子検査市場:主要企業の概要

  • F. Hoffmann-La Roche Ltd.
    • 企業概要
  • Danaher Corporation
  • Abbott Laboratories
  • Siemens Healthcare
  • Qiagen N.V.
  • Hologic, Inc.
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer, Inc.
  • Transgenomic, Inc.

第10章 遺伝子検査市場のパイプライン製品

第11章 資本取引環境

  • 資産取引 (1件)
  • 事業提携 (1件)

第12章 近年の動向

  • 企業からの発表内容 (全8件)
  • 決算発表 (全24件)
  • 法令・規制の動向 (全2件)
  • その他の主な動き (全10件)
  • 戦略・事業計画 (全11件)

第13章 付録

図表一覧

目次
Product Code: GDMECR0329DB

GlobalData's new report, "EU5 Genetic Testing Market Outlook to 2021", provides key market data on the EU5 Genetic Testing market. The report provides value, in millions of US dollars within market segments - Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Genetic Testing market includes Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests.
  • Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Genetic Testing market.
  • Global corporate-level profiles of key companies operating within the EU5 Genetic Testing market.
  • Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Danaher Corporation, Abbott Laboratories, Hologic, Inc., Cepheid, Bio-Rad Laboratories, Inc., Qiagen N.V., Transgenomic, Inc. and PerkinElmer, Inc.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Genetic Testing Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Genetic Testing Market, EU5

  • 3.1. Genetic Testing Market, EU5, Revenue ($m), 2007-2021
  • 3.2. Genetic Testing Market, EU5, Category Comparison by Revenue ($m), 2007-2021
  • 3.3. Genetic Testing Market, EU5, Revenue ($m), 2007-2014
  • 3.4. Genetic Testing Market, EU5, Revenue ($m), 2014-2021
  • 3.5. Genetic Testing Market, EU5, Company Share by Revenue ($m), 2014

4. Genetic Testing Market, France

  • 4.1. Genetic Testing Market, France, Revenue ($m), 2007-2014
  • 4.2. Genetic Testing Market, France, Revenue ($m), 2014-2021
  • 4.3. Genetic Testing Market, France, Distribution Share by Revenue ($m), 2013-2014
  • 4.4. Genetic Testing Market, France, Company Share by Revenue ($m), 2014

5. Genetic Testing Market, Germany

  • 5.1. Genetic Testing Market, Germany, Revenue ($m), 2007-2014
  • 5.2. Genetic Testing Market, Germany, Revenue ($m), 2014-2021
  • 5.3. Genetic Testing Market, Germany, Distribution Share by Revenue ($m), 2013-2014
  • 5.4. Genetic Testing Market, Germany, Company Share by Revenue ($m), 2014

6. Genetic Testing Market, Italy

  • 6.1. Genetic Testing Market, Italy, Revenue ($m), 2007-2014
  • 6.2. Genetic Testing Market, Italy, Revenue ($m), 2014-2021
  • 6.3. Genetic Testing Market, Italy, Distribution Share by Revenue ($m), 2013-2014
  • 6.4. Genetic Testing Market, Italy, Company Share by Revenue ($m), 2014

7. Genetic Testing Market, Spain

  • 7.1. Genetic Testing Market, Spain, Revenue ($m), 2007-2014
  • 7.2. Genetic Testing Market, Spain, Revenue ($m), 2014-2021
  • 7.3. Genetic Testing Market, Spain, Distribution Share by Revenue ($m), 2013-2014
  • 7.4. Genetic Testing Market, Spain, Company Share by Revenue ($m), 2014

8. Genetic Testing Market, United Kingdom

  • 8.1. Genetic Testing Market, United Kingdom, Revenue ($m), 2007-2014
  • 8.2. Genetic Testing Market, United Kingdom, Revenue ($m), 2014-2021
  • 8.3. Genetic Testing Market, United Kingdom, Distribution Share by Revenue ($m), 2013-2014
  • 8.4. Genetic Testing Market, United Kingdom, Company Share by Revenue ($m), 2014

9. Overview of Key Companies in EU5 Genetic Testing Market

  • 9.1. F. Hoffmann-La Roche Ltd.
    • 9.1.1. Company Overview
  • 9.2. Danaher Corporation
    • 9.2.1. Company Overview
  • 9.3. Abbott Laboratories
    • 9.3.1. Company Overview
  • 9.4. Siemens Healthcare
    • 9.4.1. Company Overview
  • 9.5. Qiagen N.V.
    • 9.5.1. Company Overview
  • 9.6. Hologic, Inc.
    • 9.6.1. Company Overview
  • 9.7. Bio-Rad Laboratories, Inc.
    • 9.7.1. Company Overview
  • 9.8. PerkinElmer, Inc.
    • 9.8.1. Company Overview
  • 9.9. Transgenomic, Inc.
    • 9.9.1. Company Overview

10. Genetic Testing Market Pipeline Products

11. Financial Deals Landscape

  • 11.1. Asset Transactions
    • 11.1.1. Sequenom Acquires Noninvasive Prenatal Testing Intellectual Property from Isis Innovation for USD14.5 Million
  • 11.2. Partnerships
    • 11.2.1. KromaTiD Enters into Distribution Agreement with Tebu-bio

12. Recent Developments

  • 12.1. Corporate Communications
    • 12.1.1. Sep 21, 2015: Biotage and CEO Torben Jorgensen Have Agreed to Extend Period of Service
    • 12.1.2. Jun 04, 2015: Scientific Advisory Board at Centogene
    • 12.1.3. May 29, 2015: Syngene appoints talented, new International Sales Manager to provide client driven support for its high quality image analysis systems
    • 12.1.4. May 19, 2015: Surgery Followed by Ipilimumab Treatment in Melanoma Patients Improves Survival, Say Moffitt Cancer Center Researchers
    • 12.1.5. Jan 21, 2015: Almac Appoints VP Quality and Regulatory Affairs
    • 12.1.6. Dec 01, 2014: Proteome Sciences Announces Directorate Change
    • 12.1.7. Oct 16, 2014: Proteome Sciences Announces Appointment of Non-Executive Director
    • 12.1.8. Sep 30, 2014: Proteome Sciences Announces Appointment Of New Finance Director
  • 12.2. Financial Announcements
    • 12.2.1. Sep 17, 2015: Alphatec's Arsenal Spinal Fixation System Further Expanded to Address Broader Market
    • 12.2.2. Aug 25, 2015: Exiqon: Continued strong performance in the second quarter with 24% growth and profitability
    • 12.2.3. Aug 13, 2015: Interim report January - June 2015
    • 12.2.4. Aug 06, 2015: Epigenomics Announces Q2 2015 and 6M 2015 Financial Results and Reports on Operational Highlights
    • 12.2.5. Jul 29, 2015: QIAGEN reports results for second quarter and first half of 2015
    • 12.2.6. Jul 16, 2015: First made-in-singapore cancer drug enters clinical testing
    • 12.2.7. Jul 13, 2015: OncoGenex Announces Custirsen Phase 3 "ENSPIRIT" Trial Continues Following Completion of Final Futility Survival Analysis
    • 12.2.8. Jun 16, 2015: Alkermes to Present Data On ALKS 3831 From Late-Stage CNS Portfolio at Upcoming American Society of Clinical Psychopharmacology Annual Meeting
    • 12.2.9. Jun 16, 2015: MediciNova Announces New Article Published on MN-166 in Addiction Biology
    • 12.2.10. Jun 04, 2015: Momenta Pharmaceuticals Announces Oral and Poster Presentations Relating to Novel Autoimmune Programs at EULAR 2015
    • 12.2.11. Jun 04, 2015: Catabasis Pharmaceuticals Announces Preliminary Phase 1 Data for Hypercholesterolemia Product Candidate CAT-2054
    • 12.2.12. May 29, 2015: Proteome Sciences: Preliminary Results for Year Ended 31st December, 2014
    • 12.2.13. May 12, 2015: Epigenomics Announces Q1 2015 Financial Results and Reports on Operational Highlights
    • 12.2.14. May 05, 2015: QIAGEN Reports Results for First Quarter 2015
    • 12.2.15. Apr 01, 2015: The Medicines Company Settles Angiomax (Bivalirudin) Patent Litigation With Sun
    • 12.2.16. Mar 26, 2015: Diaxonhit Announces 2014 Annual Results
    • 12.2.17. Mar 25, 2015: Epigenomics Reports Results for the Financial Year Ended December 31, 2014 and Provides Outlook for 2015
    • 12.2.18. Feb 12, 2015: Biotage: Year-End Report for 2014
    • 12.2.19. Jan 26, 2015: DIAXONHIT - 2014 Consolidated Income
    • 12.2.20. Jan 21, 2015: Cohera Medical Enters Agreement with B. Braun Surgical for Distribution of TissuGlu Surgical Adhesive in Select European Countries
    • 12.2.21. Dec 02, 2014: OGT announces operational and financial highlights for FY 2014
    • 12.2.22. Nov 11, 2014: Epigenomics Announces 2014 Third Quarter and Nine Month Financial Results and Reports on Operational Highlights
    • 12.2.23. Oct 30, 2014: Biotage Interim Report For The Period January-September 2014
    • 12.2.24. Sep 30, 2014: Proteome Sciences Unaudited Interim Results For The Six Months Ended 30th June 2014
  • 12.3. Legal And Regulatory
    • 12.3.1. Jun 16, 2015: Biotage Continued Success in Re-Examination Proceedings
    • 12.3.2. Nov 11, 2014: Genovis files complaint for patent infringement by Promega
  • 12.4. Other Significant Developments
    • 12.4.1. Aug 19, 2015: UC Davis Scientists Spot Mutations in Circulating Tumor DNA with Ingenuity Variant Analysis
    • 12.4.2. Jul 06, 2015: Microarray Instrument from Arrayjet amplifies production at Reproductive Health Science
    • 12.4.3. Jun 11, 2015: SYGNIS signs second non-exclusive distribution agreement for Asia with Welgene Biotech in Taiwan
    • 12.4.4. Jun 08, 2015: BHF extends funding for genetic testing of Familial Hypercholesterolaemia
    • 12.4.5. Apr 27, 2015: Linkage Biosciences Partners With Italian Distributor
    • 12.4.6. Mar 11, 2015: Seven Bridges Genomics UK to receive £1.95 Million to Launch Graph Genome
    • 12.4.7. Mar 11, 2015: Genomics England announces successful companies in Small Business Research Initiative for a share of £8 million
    • 12.4.8. Feb 05, 2015: IntegraGen Announces Distribution Agreement for Autism Risk Assessment Test
    • 12.4.9. Jan 16, 2015: Agilent Technologies Names Alacris Theranostics as Certified Provider of Target Enrichment Services
    • 12.4.10. Nov 27, 2014: Wieslab Laboratory Services launches new PANDAS/PANS website
  • 12.5. Product News
    • 12.5.1. Aug 29, 2015: Oxford starts recruiting to 100,000. Genomes Project
    • 12.5.2. Jul 28, 2015: OGT expands its portfolio of Cytocell pathology FISH probes
    • 12.5.3. Jun 30, 2015: Exiqon integrates RNAseq workflow in unique cloud-computing environment, XploreRNA
    • 12.5.4. Apr 23, 2015: Desktop Genetics Announces the Launch of DeskGen Gene Editing Platform
    • 12.5.5. Apr 23, 2015: Merck Millipore Introduces Magna ChIRP RNA Interactome Kits for the Analysis of Chromatin-Associated RNAs
    • 12.5.6. Apr 08, 2015: Genetic screening could improve breast cancer prevention
    • 12.5.7. Apr 02, 2015: Hospital trust to launch revolutionary electronic health records system
    • 12.5.8. Jan 27, 2015: Scientist to develop tool to help women with breast cancer make decisions about genetic testing
    • 12.5.9. Nov 25, 2014: Sophia Genetics' launches full BRCA1 and BRCA2 analysis in a single clinical grade NGS experiment
    • 12.5.10. Oct 30, 2014: New Biotage SNAP ULTRA C18 Cartridges - High Performance Reversed Phase Flash Purification
    • 12.5.11. Oct 20, 2014: Almac Introduce Flexible Clinical Trial Direct To Patient Solution
  • 12.6. Strategy And Business Planning
    • 12.6.1. Jul 10, 2015: Almac Group Expands Asia Pacific Presence with New Regional Headquarters and Clinical Trial Supply Facility in Singapore
    • 12.6.2. Jun 06, 2015: British Healthcare Institutions Lead the Way with Cutting Edge Genetic Analysis Technology to Better Examine Cancers and Congenital Diseases
    • 12.6.3. May 04, 2015: QIAGEN Partners With World's Largest Sequencing Provider
    • 12.6.4. Apr 22, 2015: Transgenomic to Incorporate Horizon Discovery's Genomic Reference Standards into Multiplexed ICE COLD-PCR Kits
    • 12.6.5. Mar 10, 2015: Gentronix Announces Full Membership of the UK GLP Monitoring Programme and Introduction of GLP in vitro Genotoxicity Services
    • 12.6.6. Feb 05, 2015: TTP Labtech and Almac Group's Strategic Alliance Consolidates Fluorescence Lifetime Technology to Form a One-Stop Shop for Compound Screening
    • 12.6.7. Jan 27, 2015: PreAnalytiX, NuGEN Technologies and RUCDR Infinite Biologics Partner to Develop Clinically Validated RNA-Seq Workflow for Whole Blood Samples
    • 12.6.8. Jan 23, 2015: EKF collaborates with ANGLE to investigate the combination of Parsortix circulating tumour cell harvesting platform with PointMan DNA enrichment technology
    • 12.6.9. Nov 26, 2014: ChemPartner and Active Motif form an Epigenetic Biochemical Technology Alliance
    • 12.6.10. Nov 11, 2014: Horizon Discovery Group Establishes Scientific Advisory Board for Horizon Diagnostics Business Unit
    • 12.6.11. Sep 30, 2014: Almac Doubles Global 2-8°C Cold Room Capacity in Response to Increasing Biologics Demand

13. Appendix

  • 13.1. Research Methodology
    • 13.1.1. Coverage
    • 13.1.2. Secondary Research
    • 13.1.3. Primary Research
    • 13.1.4. Company Share Analysis
    • 13.1.5. Distribution Share Analysis
  • 13.2. GlobalData Consulting
  • 13.3. Contact Us
  • 13.4. Disclaimer

List of Tables

  • Table 1: Genetic Testing Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2007-2021
  • Table 2: Genetic Testing Market, EU5, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Table 3: Genetic Testing Market, EU5, Revenue ($m), Historic, USD Constant, 2007-2014
  • Table 4: Genetic Testing Market, EU5, Revenue ($m), Forecast, USD Constant, 2014-2021
  • Table 5: Genetic Testing Market, EU5, Company Share by Revenue ($m), USD Constant, 2014
  • Table 6: Genetic Testing Market, France, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 7: Genetic Testing Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 8: Genetic Testing Market, France, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 9: Genetic Testing Market, France, Company Share by Revenue ($m), USD Constant, 2014
  • Table 10: Genetic Testing Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 11: Genetic Testing Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 12: Genetic Testing Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 13: Genetic Testing Market, Germany, Company Share by Revenue ($m), USD Constant, 2014
  • Table 14: Genetic Testing Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 15: Genetic Testing Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 16: Genetic Testing Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 17: Genetic Testing Market, Italy, Company Share by Revenue ($m), USD Constant, 2014
  • Table 18: Genetic Testing Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 19: Genetic Testing Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 20: Genetic Testing Market, Spain, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 21: Genetic Testing Market, Spain, Company Share by Revenue ($m), USD Constant, 2014
  • Table 22: Genetic Testing Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 23: Genetic Testing Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 24: Genetic Testing Market, United Kingdom, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 25: Genetic Testing Market, United Kingdom, Company Share by Revenue ($m), USD Constant, 2014
  • Table 26: Genetic Testing Market Pipeline Products
  • Table 27: Sequenom Acquires Noninvasive Prenatal Testing Intellectual Property from Isis Innovation for USD14.5 Million
  • Table 28: KromaTiD Enters into Distribution Agreement with Tebu-bio

List of Figures

  • Figure 1: Genetic Testing Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2007-2021
  • Figure 2: Genetic Testing Market, EU5, Category Comparison by Revenue ($m), USD Constant, 2007-2021
  • Figure 3: Genetic Testing Market, EU5, Revenue ($m), Historic, USD Constant, 2007-2014
  • Figure 4: Genetic Testing Market, EU5, Revenue ($m), Forecast, USD Constant, 2014-2021
  • Figure 5: Genetic Testing Market, EU5, Company Share (%) 2014
  • Figure 6: Genetic Testing Market, France, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 7: Genetic Testing Market, France, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 8: Genetic Testing Market, France, Company Share (%) 2014
  • Figure 9: Genetic Testing Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 10: Genetic Testing Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 11: Genetic Testing Market, Germany, Company Share (%) 2014
  • Figure 12: Genetic Testing Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 13: Genetic Testing Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 14: Genetic Testing Market, Italy, Company Share (%) 2014
  • Figure 15: Genetic Testing Market, Spain, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 16: Genetic Testing Market, Spain, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 17: Genetic Testing Market, Spain, Company Share (%) 2014
  • Figure 18: Genetic Testing Market, United Kingdom, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 19: Genetic Testing Market, United Kingdom, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 20: Genetic Testing Market, United Kingdom, Company Share (%) 2014
Back to Top